Research Paper Volume 14, Issue 21 pp 8700—8718
Identification and validation of a glycolysis-related gene signature for depicting clinical characteristics and its relationship with tumor immunity in patients with colon cancer
Figure 3. Text efficacy of the gene model in CC patients. (A) CC patient distribution according to the median risk score. (B) Kaplan–Meier analysis between the low- and high-risk groups. (C) ROC analysis of the risk score. (D) Model gene expression in the low- and high-risk groups. (E) The relationship between patient survival status and risk score. (F) PCA between the low- and high-risk groups.